{
    "clinical_study": {
        "@rank": "100693", 
        "arm_group": [
            {
                "arm_group_label": "Necrotizing fasciitis proven", 
                "description": "Histological evidence of necrotizing fasciitis at initial surgical debridement"
            }, 
            {
                "arm_group_label": "Not necrotizing fasciitis", 
                "description": "A composite of those with no histological tissue necrosis at initial surgical debridement, and those clinically judged not to be a necrotizing infection who therefore did not undergo surgery."
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators examined the hypothesis that serum lactate is raised in early necrotizing\n      fasciitis to a much greater extent than in other differential diagnoses, such as severe\n      cellulitis, and therefore provides a diagnostic indicator."
        }, 
        "brief_title": "Exploratory Study of Raised Serum Lactate as a Marker of Necrotizing Fasciitis", 
        "completion_date": {
            "#text": "September 2010", 
            "@type": "Actual"
        }, 
        "condition": "Fasciitis, Necrotizing", 
        "condition_browse": {
            "mesh_term": [
                "Fasciitis", 
                "Fasciitis, Necrotizing"
            ]
        }, 
        "detailed_description": {
            "textblock": "A prospective comparison of serum lactate levels at referral to the Plastic Surgery team to\n      the 'gold standard' test of histology at initial surgical debridement, looking at 53\n      consecutive patients referred with suspected necrotizing fasciitis to a single surgeon at\n      one institution between 2000 and 2010."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Referral to one consultant (Mr A Armstrong) at one institution (Wexham Park Hospital)\n             with a suspected diagnosis of necrotizing fasciitis between September 2000 and\n             September 2010\n\n        Exclusion Criteria:\n\n          -  Nil"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients referred to a single surgeon at one institution over 10 years (September 2000\n        - September 2010) with a suspected diagnosis of necrotizing fasciitis. Patients were\n        followed for the duration of their hospital stay."
            }
        }, 
        "enrollment": {
            "#text": "53", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01739959", 
            "org_study_id": "WPH/NF/2000-2010"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Necrotizing fasciitis", 
            "Fournier's gangrene", 
            "Cellulitis", 
            "Serum Lactate"
        ], 
        "lastchanged_date": "November 28, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Slough", 
                    "country": "United Kingdom", 
                    "state": "London", 
                    "zip": "SL2 4HL"
                }, 
                "name": "Wexham Park Hospital"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_groups": "2", 
        "official_title": "Raised Serum Lactate as a Marker of Necrotizing Fasciitis; a Consecutive Prospective Review.", 
        "overall_official": {
            "affiliation": "Wexham Park Hospital", 
            "last_name": "George Murphy, MRCS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United Kingdom: National Health Service", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Serum lactate level at initial referral to the plastic surgery team, as measured by arterial blood gas analysis (calibrated point-of-care testing). Levels compared between the group with confirmed histological necrosis at initial surgical debridement, versus those with no evidence of necrosis (a composite of those who did not undergo surgery as they were judged not to have necrotizing fasciitis, and those who did undergo surgery, but whose histology did not show tissue necrosis).", 
            "measure": "Serum lactate level", 
            "safety_issue": "No", 
            "time_frame": "At referral to the Plastic Surgery Team"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01739959"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National Health Service, United Kingdom", 
            "investigator_full_name": "George Murphy", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "National Health Service, United Kingdom", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Health Service, United Kingdom", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2000", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2012"
    }
}